Some enzymes involved in this process, as protein kinase B (AKT) and glycogen synthase kinase-3-beta (GSK 3), prevent the development of cardiac hypertrophy and their activity is reported to be higher in females [41, 42]. This evidence concerns the gene AKT1 and cardiac hypertrophy.